<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://healthandtechnow.com/articles/aca-broker-moratorium-stayed-19000-agents/</loc>
    <news:news>
      <news:publication>
        <news:name>Health and Tech Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-07T10:58:00-06:00</news:publication_date>
      <news:title>Court lifts CMS freeze on 19,000 new ACA brokers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://healthandtechnow.com/articles/medicare-one-time-gene-therapy-12-month-price-rule/</loc>
    <news:news>
      <news:publication>
        <news:name>Health and Tech Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-07T10:58:00-06:00</news:publication_date>
      <news:title>Medicare will price one-dose gene therapies as 12 months</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://healthandtechnow.com/articles/hims-hers-lilly-zepbound-299-foundayo-149/</loc>
    <news:news>
      <news:publication>
        <news:name>Health and Tech Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-07T07:07:00-06:00</news:publication_date>
      <news:title>Hims &amp; Hers adds Lilly&apos;s Zepbound at $299, Foundayo at $149</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://healthandtechnow.com/articles/cms-drug-price-negotiation-permanent-20-drugs-2029/</loc>
    <news:news>
      <news:publication>
        <news:name>Health and Tech Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-07T07:06:00-06:00</news:publication_date>
      <news:title>CMS makes drug price talks permanent: up to 20 drugs a year</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://healthandtechnow.com/articles/humana-q3-2026-raises-adjusted-eps-9-50/</loc>
    <news:news>
      <news:publication>
        <news:name>Health and Tech Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T10:19:00-06:00</news:publication_date>
      <news:title>Humana raises Adjusted EPS floor to at least $9.50 after Q3</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://healthandtechnow.com/articles/opps-2027-340b-hospitals-outpatient-losses/</loc>
    <news:news>
      <news:publication>
        <news:name>Health and Tech Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-06T09:00:00-06:00</news:publication_date>
      <news:title>340B hospitals carry 99.0% of $3.10 billion in 2027 outpatient losses</news:title>
    </news:news>
  </url>
</urlset>
